Stojko M, Nocon J, Pilat P, Szpila G, Smolarczyk J, Zmudka K
Medicina (Kaunas). 2023; 59(8).
PMID: 37629729
PMC: 10456445.
DOI: 10.3390/medicina59081439.
Pope Jr H, Kanayama G, Hudson J, Kaufman M
Am J Addict. 2021; 30(5):423-432.
PMID: 33870584
PMC: 8995103.
DOI: 10.1111/ajad.13157.
Sublette M
Curr Top Behav Neurosci. 2020; 46:155-177.
PMID: 32840861
DOI: 10.1007/7854_2020_163.
Estumano D, Ferreira L, Bezerra P, Silva M, Jardim G, Santos G
Front Endocrinol (Lausanne). 2019; 10:654.
PMID: 31616380
PMC: 6768956.
DOI: 10.3389/fendo.2019.00654.
Piacentino D, Kotzalidis G, Del Casale A, Aromatario M, Pomara C, Girardi P
Curr Neuropharmacol. 2015; 13(1):101-21.
PMID: 26074746
PMC: 4462035.
DOI: 10.2174/1570159X13666141210222725.
Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G, Hudson J, Deluca J, Isaacs S, Baggish A, Weiner R
Addiction. 2015; 110(5):823-31.
PMID: 25598171
PMC: 4398624.
DOI: 10.1111/add.12850.
Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.
Kanayama G, Brower K, Wood R, Hudson J, Pope Jr H
Drug Alcohol Depend. 2010; 109(1-3):6-13.
PMID: 20188494
PMC: 2875348.
DOI: 10.1016/j.drugalcdep.2010.01.011.
Illicit anabolic-androgenic steroid use.
Kanayama G, Hudson J, Pope Jr H
Horm Behav. 2009; 58(1):111-21.
PMID: 19769977
PMC: 2883629.
DOI: 10.1016/j.yhbeh.2009.09.006.
Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?.
Kanayama G, Hudson J, Pope Jr H
Drug Alcohol Depend. 2008; 98(1-2):1-12.
PMID: 18599224
PMC: 2646607.
DOI: 10.1016/j.drugalcdep.2008.05.004.
Anabolic-androgenic steroid dependence? Insights from animals and humans.
Wood R
Front Neuroendocrinol. 2008; 29(4):490-506.
PMID: 18275992
PMC: 2585375.
DOI: 10.1016/j.yfrne.2007.12.002.
Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol.
Frye C
Pharmacol Biochem Behav. 2006; 86(2):354-67.
PMID: 17112575
PMC: 1857333.
DOI: 10.1016/j.pbb.2006.10.003.
Behavioural manifestations of anabolic steroid use.
Trenton A, Currier G
CNS Drugs. 2005; 19(7):571-95.
PMID: 15984895
DOI: 10.2165/00023210-200519070-00002.
Effects of androgenic-anabolic steroids in athletes.
Hartgens F, Kuipers H
Sports Med. 2004; 34(8):513-54.
PMID: 15248788
DOI: 10.2165/00007256-200434080-00003.
Weight training. A potential confounding factor in examining the psychological and behavioural effects of anabolic-androgenic steroids.
Bahrke M, Yesalis 3rd C
Sports Med. 1994; 18(5):309-18.
PMID: 7871292
DOI: 10.2165/00007256-199418050-00003.
Recent developments in the toxicology of anabolic steroids.
Graham S, Kennedy M
Drug Saf. 1990; 5(6):458-76.
PMID: 2285499
DOI: 10.2165/00002018-199005060-00007.
Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review.
Bahrke M, Yesalis 3rd C, Wright J
Sports Med. 1990; 10(5):303-37.
PMID: 2263798
DOI: 10.2165/00007256-199010050-00003.
